96 related articles for article (PubMed ID: 15003542)
1. Defective phosphatidic acid-phospholipase C signaling in diabetic cardiomyopathy.
Tappia PS; Maddaford TG; Hurtado C; Dibrov E; Austria JA; Sahi N; Panagia V; Pierce GN
Biochem Biophys Res Commun; 2004 Mar; 316(1):280-9. PubMed ID: 15003542
[TBL] [Abstract][Full Text] [Related]
2. Responses of heart function and intracellular free Ca2+ to phosphatidic acid in chronic diabetes.
Xu YJ; Botsford MW; Panagia V; Dhalla NS
Can J Cardiol; 1996 Oct; 12(10):1092-8. PubMed ID: 9191503
[TBL] [Abstract][Full Text] [Related]
3. Depressed responsiveness of phospholipase C isoenzymes to phosphatidic acid in congestive heart failure.
Tappia PS; Yu CH; Di Nardo P; Pasricha AK; Dhalla NS; Panagia V
J Mol Cell Cardiol; 2001 Mar; 33(3):431-40. PubMed ID: 11181012
[TBL] [Abstract][Full Text] [Related]
4. Depressed phosphatidic acid-induced contractile activity of failing cardiomyocytes.
Tappia PS; Maddaford TG; Hurtado C; Panagia V; Pierce GN
Biochem Biophys Res Commun; 2003 Jan; 300(2):457-63. PubMed ID: 12504106
[TBL] [Abstract][Full Text] [Related]
5. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy.
Krüger M; Babicz K; von Frieling-Salewsky M; Linke WA
J Mol Cell Cardiol; 2010 May; 48(5):910-6. PubMed ID: 20184888
[TBL] [Abstract][Full Text] [Related]
6. Effects of streptozotocin-induced diabetes on contraction and calcium transport in rat ventricular cardiomyocytes.
Bracken N; Howarth FC; Singh J
Ann N Y Acad Sci; 2006 Nov; 1084():208-22. PubMed ID: 17151303
[TBL] [Abstract][Full Text] [Related]
7. Restoration of cardiomyocyte function in streptozotocin-induced diabetic rats after treatment with vanadate in a tea decoction.
Clark TA; Maddaford TG; Tappia PS; Heyliger CE; Ganguly PK; Pierce GN
Curr Pharm Biotechnol; 2010 Dec; 11(8):906-10. PubMed ID: 20874687
[TBL] [Abstract][Full Text] [Related]
8. Effects of brain natriuretic peptide on contraction and intracellular Ca2+ in ventricular myocytes from the streptozotocin-induced diabetic rat.
Howarth FC; Al-Shamsi N; Al-Qaydi M; Al-Mazrouei M; Qureshi A; Chandranath SI; Kazzam E; Adem A
Ann N Y Acad Sci; 2006 Nov; 1084():155-65. PubMed ID: 17151299
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine-induced changes in gene expression of phospholipase C in cardiomyocytes.
Singal T; Dhalla NS; Tappia PS
J Mol Cell Cardiol; 2006 Jul; 41(1):126-37. PubMed ID: 16714034
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidic acid: a potential signal transducer for cardiac hypertrophy.
Dhalla NS; Xu YJ; Sheu SS; Tappia PS; Panagia V
J Mol Cell Cardiol; 1997 Nov; 29(11):2865-71. PubMed ID: 9405162
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 stimulates phospholipase Cbeta in adult cardiomyocytes.
Tappia PS; Padua RR; Panagia V; Kardami E
Biochem Cell Biol; 1999; 77(6):569-75. PubMed ID: 10668634
[TBL] [Abstract][Full Text] [Related]
12. Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy.
Tappia PS; Asemu G; Aroutiounova N; Dhalla NS
Mol Cell Biochem; 2004 Jun; 261(1-2):193-9. PubMed ID: 15362504
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart.
Hu Y; Belke D; Suarez J; Swanson E; Clark R; Hoshijima M; Dillmann WH
Circ Res; 2005 May; 96(9):1006-13. PubMed ID: 15817886
[TBL] [Abstract][Full Text] [Related]
14. Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy.
Stølen TO; Høydal MA; Kemi OJ; Catalucci D; Ceci M; Aasum E; Larsen T; Rolim N; Condorelli G; Smith GL; Wisløff U
Circ Res; 2009 Sep; 105(6):527-36. PubMed ID: 19679837
[TBL] [Abstract][Full Text] [Related]
15. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase C may be involved in norepinephrine-induced cardiac hypertrophy.
Singal T; Dhalla NS; Tappia PS
Biochem Biophys Res Commun; 2004 Jul; 320(3):1015-9. PubMed ID: 15240149
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-dependent elevation of inositol 1,4,5-trisphosphate level induced by freezing or homogenization of tissues and cells.
Sandnes D; Nilssen LS; Andersen GO; Viko H; Sjetnan AE; Skomedal T; Osnes JB
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):288-94. PubMed ID: 15569274
[TBL] [Abstract][Full Text] [Related]
18. Impairment of the sarcolemmal phospholipase D-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy.
Williams SA; Tappia PS; Yu CH; Bibeau M; Panagia V
J Mol Cell Cardiol; 1998 Jan; 30(1):109-18. PubMed ID: 9500869
[TBL] [Abstract][Full Text] [Related]
19. Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats.
Shao CH; Rozanski GJ; Patel KP; Bidasee KR
J Mol Cell Cardiol; 2007 Jan; 42(1):234-46. PubMed ID: 17027851
[TBL] [Abstract][Full Text] [Related]
20. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes.
Kang SM; Lim S; Song H; Chang W; Lee S; Bae SM; Chung JH; Lee H; Kim HG; Yoon DH; Kim TW; Jang Y; Sung JM; Chung NS; Hwang KC
Eur J Pharmacol; 2006 Mar; 535(1-3):212-9. PubMed ID: 16516885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
